Akso Health Group (AHG)
USD 1.38
(-25.0%)
USD 1.38
(-25.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.35 Million | -3.25 Million | -8.62 Million | 10.05 Million | -55.86 Million | -1.73 Million |
| Net Income | -9.11 Million | -13.08 Million | -16.84 Million | -34.71 Million | -71.19 Million | 5.53 Million |
| Depreciation & Amortization | - | - | 18.39 Thousand | 15.16 Thousand | 580.5 Thousand | 406.79 Thousand |
| Deferred income taxes | - | - | - | 26.75 Million | 3.58 Billion | -3.72 Billion |
| Stock-based compensation | - | - | 391.62 Thousand | 55.46 Thousand | 347.46 Thousand | 6.58 Million |
| Change in working capital | 2.05 Million | -1.17 Million | -2.56 Million | 21.11 Million | -30.9 Million | -15.34 Million |
| Other non-cash items | 395.91 Thousand | 11 Million | 10.37 Million | -3.16 Million | -3.53 Billion | 3.72 Billion |
| Investing Cash Flow | -54.72 Million | 18.47 Million | -19.96 Million | -662.00 | 12.77 Million | -68.1 Million |
| Investments in PPE | - | - | -4861.00 | - | -314.52 Thousand | -944.81 Thousand |
| Acquisitions | -56.25 Million | - | - | - | 7815.00 | 5901.00 |
| Investment purchases | - | - | - | - | -14.59 Million | -16.5 Million |
| Sales/Maturities of investments | - | - | - | - | -7815.00 | -5901.00 |
| Other Investing Activities | -54.72 Million | 18.47 Million | -19.95 Million | -662.00 | 27.68 Million | -50.66 Million |
| Financing Cash Flow | 131.65 Million | -27.51 Million | 34.78 Million | -9.03 Million | -3.96 Million | -29.37 Thousand |
| Debt repayment | -7.68 Million | -27.51 Million | -10 Million | -10 Million | - | -20 Million |
| Dividends payments | - | - | - | - | - | -19.54 Million |
| Common Stock Repurchased | - | - | - | - | -2.66 Million | -1.32 Million |
| Common Stock Issuance | 139.33 Million | - | 10.01 Million | 5.00 | 281.61 Thousand | 838.62 Thousand |
| Other Financing Activities | 131.65 Million | -27.51 Million | 34.76 Million | 962.77 Thousand | -1.57 Million | 40 Million |
| Accounts receivables | 327.18 Thousand | -8.09 Million | 13.89 Thousand | -25.42 Thousand | -183.91 Thousand | -418.63 Thousand |
| Accounts payables | 166.04 Thousand | 712.88 Thousand | -104.24 Thousand | -82.09 Thousand | -176.6 Thousand | - |
| Inventory | 1.49 Million | 6.1 Million | -7.79 Million | 20.51 Million | 176.6 Thousand | - |
| Other working capital | 220.64 Thousand | 102.41 Thousand | 5.32 Million | 700.14 Thousand | -30.71 Million | -14.92 Million |
| Cash at beginning of period | 9.19 Million | 21.92 Million | 15.12 Million | 10.92 Million | 57.37 Million | 132.62 Million |
| Cash at end of period | 86.2 Million | 9.19 Million | 21.92 Million | 15.12 Million | 10.92 Million | 57.37 Million |
| Capital Expenditure | - | - | -4861.00 | - | -314.52 Thousand | -944.81 Thousand |
| Effect of forex changes on cash | -1.27 Million | -436.51 Thousand | 607.71 Thousand | 3.18 Million | 608.63 Thousand | -5.38 Million |
| Net cash flow / Change in cash | 77.01 Million | -12.73 Million | 6.79 Million | 4.2 Million | -46.44 Million | -75.25 Million |
| Free Cash Flow | 1.35 Million | -3.25 Million | -8.63 Million | 10.05 Million | -56.18 Million | -2.67 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.11 Million | -3 Million | -3 Million | -1.72 Million | -1.72 Million | -1.08 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.05 Million | 590.78 Thousand | 590.78 Thousand | 255.04 Thousand | 255.04 Thousand | -536.45 Thousand |
| Other non-cash items | 395.91 Thousand | 2.96 Million | 2.96 Million | 1.59 Million | 1.59 Million | 661.97 Thousand |
| Investing Cash Flow | -54.72 Million | -28.12 Million | -28.12 Million | 764.45 Thousand | 764.45 Thousand | -764.45 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -56.25 Million | -28.12 Million | -28.12 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -54.72 Million | -55 Million | - | 764.45 Thousand | 764.45 Thousand | -764.45 Thousand |
| Financing Cash Flow | 131.65 Million | 65.65 Million | 65.65 Million | 175 Thousand | 175 Thousand | 1.00 |
| Debt repayment | -7.68 Million | -8.07 Million | - | -350 Thousand | - | -28 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 139.33 Million | 140.06 Million | - | - | - | - |
| Other Financing Activities | 131.65 Million | 65.65 Million | 65.65 Million | 175 Thousand | 175 Thousand | 1.00 |
| Accounts receivables | 327.18 Thousand | 1706.98 | - | 163.59 Thousand | 163.59 Thousand | -91.75 Thousand |
| Accounts payables | 166.04 Thousand | - | - | -1.00 | - | -1.00 |
| Inventory | 1.49 Million | 518.06 Thousand | 518.06 Thousand | 229.55 Thousand | 229.55 Thousand | -393.44 Thousand |
| Other working capital | 220.64 Thousand | 72.72 Thousand | 72.72 Thousand | -138.1 Thousand | -138.1 Thousand | -51.25 Thousand |
| Cash at beginning of period | 9.19 Million | 9.21 Million | - | 7.92 Million | - | 9.99 Million |
| Cash at end of period | 86.2 Million | 85.17 Million | 37.35 Million | 9.21 Million | 1.15 Million | 7.92 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -1.27 Million | -728.88 Thousand | -728.88 Thousand | 92.8 Thousand | 92.8 Thousand | 1.32 Million |
| Net cash flow / Change in cash | 77.01 Million | 75.96 Million | 37.35 Million | 1.28 Million | 1.15 Million | -2.06 Million |
| Free Cash Flow | 1.35 Million | 554.45 Thousand | 554.45 Thousand | 121.16 Thousand | 121.16 Thousand | -959.61 Thousand |
TX
PIN
LUNR
ZUARIIND
BC
UVRBF